Femasys (FEMY) Stock Analysis
NASDAQHealthcareMedical - Instruments & Supplies
What Femasys does
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering. For diagnostic purposes, Femasys provides FemCerv, a biopsy device utilized for endocervical curettage, and FemEMB, a product candidate intended for endometrial sampling to assist in the detection of uterine cancer. Additionally, the company markets its FemVue saline-air device across various international regions, including the U.S., Europe, Canada, and Japan. Its infertility-related products are supplied to obstetrician-gynecologists, other allied healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. The company also offers a range of non-surgical product technologies.
Key metrics
ETFs linked to FEMY
Broad-market and Healthcare sector ETFs an investor holding Femasys is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how FEMY fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze FEMY in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Femasys?
- Femasys trades under the ticker FEMY on NASDAQ.
- Which exchange is FEMY listed on?
- FEMY is listed on NASDAQ.
- What sector does Femasys operate in?
- Femasys is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
- How can PortView help analyze FEMY in a portfolio?
- PortView shows FEMY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.